DavidAratenMD

PubMed

• 3 citations
  Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria.
  Austin Kulasekararaj, Axel Glasmacher, Peng Liu, Jeff Szer, David Araten, Geraldine Rauch, Chad Gwaltney, J Rafael Sierra, Jong Wook Lee> ;European Journal of Haematology. 2022 May 1
• 1 citations
  Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Larg...
  Jamile Shammo, Ajeet Gajra, Yogesh Patel, Ioannis Tomazos, Jonathan Kish, Anita Hill, J Rafael Sierra, David Araten> ;Journal of Blood Medicine. 2022 Jan 1
• 5 citations
  Application of counter-selectable marker PIGA in engineering designer deletion cell lines and characterization of CRISPR deletion efficiency.
  Donghui Li, Xiaoji Sun, Fangzhou Yu, Mary Ann Perle, David J Araten, Jef D. Boeke> ;Nucleic Acids Research. 2021 Mar 18
• 3 citations
  Beneficial effects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International Paroxysmal Nocturnal Hemoglobinuria Registry.
  Alexander Röth, David J. Araten, Loree Larratt, Austin G. Kulasekararaj, Jaroslaw P. Maciejewski, Amanda Wilson, Philippe Gustovic, Yuzuru Kanakura> ;European Journal of Haematology. 2020 Nov 1
• 19 citations
  Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders.
  David J. Araten, H. Michael Belmont, Julia Schaefer-Cutillo, Arjun Iyengar, Aprajita Mattoo, Ramachandra Reddy> ;The American Journal of Case Reports. 2020 Sep 12
• 60 citations
  Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry
  Hubert Schrezenmeier, Alexander Röth, David J. Araten, Yuzuru Kanakura, Loree Larratt, Jamile M. Shammo, Amanda Wilson, Gilda Shayan, Jaroslaw P. Maciejewski> ;Annals of Hematology. 2020 May 10
• 3 citations
  Analysis of platelets by flow cytometry in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).
  David J. Araten, Daniel Boxer, Leah Zamechek, Erik Sherman, Michael A. Nardi> ;Blood Cells, Molecules & Diseases. 2020 Feb 1
• 1 citations
  A patient with POEMS syndrome responding to modified CyBorD chemotherapy as a bridge to autologous stem cell transplantation.
  Emily C. Milam, Kathryn J. Martires, Kristen Lo Sicco, David J. Araten, Andrew G. Franks> ;JAAD Case Reports. 2019 Feb 12
• 2 citations
  Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH).
  Camille Lobry, Ashish Bains, Leah Zamechek, Sherif Ibrahim, Iannis Aifantis, David J. Araten> ;Experimental Hematology & Oncology. 2019 Aug 21
• 31 citations
  MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.
  Nikki A. Evensen, P. Pallavi Madhusoodhan, Julia Meyer, Jason Saliba, Ashfiyah Chowdhury, David J. Araten, Jacob Nersting, Teena Bhatla, Tiffaney Vincent, David T. Tea...> ;Haematologica. 2018 May 1
• 49 citations
  Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH Registry
  Gérard Socié, Hubert Schrezenmeier, Petra Muus, Igor Lisukov, Alexander Röth, Austin G. Kulasekararaj, Jong Wook Lee, David J. Araten, Anita Hill, Robert A. Brodsky, A...> ;Internal Medicine Journal. 2016 Sep 1
• 2 citations
  No evidence of hypermutability in red cells from patients with paroxysmal nocturnal hemoglobinuria using the XK gene
  David J. Araten, Leah Zamechek, Gregory R. Halverson> ;Haematologica. 2014 May 9
• 13 citations
  Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria
  David J. Araten, Anna Paola Iori, Karen T. Brown, Giovanni Fernando Torelli, Walter Barberi, Fiammetta Natalino, Maria Stefania De Propris, Corrado Girmenia, Filippo M...> ;Journal of Hematology & Oncology. 2014 Mar 27
• 14 citations
  The rate of spontaneous mutations in human myeloid cells
  David J. Araten, Ondrej Krejci, Kimberly DiTata, Mark Wunderlich, Katie J. Sanders, Leah Zamechek, James C. Mulloy> ;Mutation Research. 2013 Sep 1
• 3 citations
  Leukemic blasts with the paroxysmal nocturnal hemoglobinuria phenotype in children with acute lymphoblastic leukemia.
  David J. Araten, Katie J. Sanders, Dan Anscher, Leah Zamechek, Stephen P. Hunger, Sherif Ibrahim> ;The American Journal of Pathology. 2012 Nov 1
• 29 citations
  Paroxysmal nocturnal hemoglobinuria in pediatric patients.
  Kevin J. Curran, Nancy A. Kernan, Susan E. Prockop, Andromachi Scaradavou, Trudy N. Small, Rachel Kobos, Hugo Castro-Malaspina, David J. Araten, Donna DiMichele, Richa...> ;Pediatric Blood & Cancer. 2012 Sep 1
• 18 citations
  Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature.
  David J. Araten, Rosario Notaro, Howard T. Thaler, Nancy A. Kernan, Farid Boulad, Hugo Castro-Malaspina, Trudy N. Small, Andromachi Scaradavou, Susan E. Prockop, Sara ...> ;Haematologica. 2012 Mar 1
• 31 citations
  Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation.
  Chiharu Sugimori, Eric Padron, Gisela Caceres, Kenneth H. Shain, Lubomir Sokol, Zhang Lm, Ramon V. Tiu, Christine L. O'Keefe, Manuel G. Afable, Michael J. Clemente, J ...> ;Blood Cancer Journal. 2012 Mar 23
• 16 citations
  Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria
  Christine L. O'Keefe, Chiharu Sugimori, Manual Afable, Michael J. Clemente, Kenneth H. Shain, David J. Araten, Alan F. List, P.K. Epling-Burnette, Jaroslaw P. Maciejewski> ;Leukemia. 2011 Feb 1
• 46 citations
  The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo.
  Benedetta Peruzzi, David J. Araten, Rosario Notaro, Lucio Luzzatto> ;Mutation Research. 2010 Jul 1
• 11 citations
  A quantitative analysis of genomic instability in lymphoid and plasma cell neoplasms based on the PIG-A gene
  David J. Araten, Jose A. Martinez-Climent, Mary Ann Perle, Eliana Holm, Leah Zamechek, Kimberly DiTata, Katie J. Sanders> ;Mutation Research. 2010 Apr 1
• 3 citations
  Spontaneously arising red cells with a McLeod-like phenotype in normal donors.
  David J. Araten, Katie J. Sanders, Jeffrey J. Pu, Soohee Lee> ;Mutation Research. 2009 Dec 1
• 9 citations
  Multiple Myeloma Involving Skin and Pulmonary Parenchyma after Autologous Stem Cell Transplantation
  Yuan Yuan, Rosemary Wieczorek, David Green, P. Cook, Harold Ballard, David J. Araten> ;Journal of Hematology & Oncology. 2009 Nov 13
• 5 citations
  Splenic infarction and subsequent splenic rupture in a patient with paroxysmal nocturnal hemoglobinuria and heparin‐induced thrombocytopenia
  Mark L. Kayton, Donna DiMichele, David J. Araten, Nancy A. Kernan, Farid Boulad, Heather Magnan> ;Pediatric Blood & Cancer. 2009 Sep 1
• 37 citations
  The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH)
  David J. Araten, Lucio Luzzatto> ;Blood. 2006 Jul 15
• Join now to see all